Antiglycation potential of commercial available extracts of two Indian medicinal plants: Pterocarpus marsupium and Artocarpus lakoocha using advanced glycation end products (AGE) competitive fluorescence assay

Figures & data

Figure 1. Structure of oxyresveratrol

Figure 2. Structure of pterostilbene

Figure 3. (a) HPLC chromatogram of Pterocarpus marsupium extract (Silbinol) with pterostilbene peak (Rt 26.51 min). (b) HPLC chromatogram of Artocarpus lakoocha extract (Artonox) with oxyresveratrol peak (Rt 11.66 min)

Figure 4. (a) Mass spectra of major peak in P. marsupium extract (Silbinol). (b) Mass spectra of major peak in A. lakoocha extract (Artonox)

Figure 5. Corrected fluorescence of Artocarpus (0, 1, 10, and 100 mg/ml) in AGE-BSA (-glucose) after 0, 24, 48, 96, 168, and 192 hours of incubation at 60°C

Figure 6. Corrected fluorescence of perocarpus extract (0, 1, 10, and 100 mg/ml) in AGE-BSA (-glucose) after 0, 24, 48, 96, 168, and 192 h of incubation at 60°C

Table 1. Background corrected antiglycation activity of A. lakoocha extract (Artonox)

Sample (background corrected) concentration		Time points (In Hours)
		96	168	192
Percentage Inhibition	1 mg/ml	46.3	67.8	71.3
	10 mg/ml	100.0	95.5	100.0
	100 mg/ml	100.0	94.9	90.7

Table 2. Background corrected antiglycation activity of P. marsupium extract (Silbinol)

Sample (background corrected) concentration		Time points (In Hours)
		96	168	192
Percentage Inhibition	1 mg/ml	44.3	50.4	39.8
	10 mg/ml	46.1	71.0	60.1
	100 mg/ml	62.7	84.6	77.2